Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today
Aura AI Summary
Key Stats
- $1.85BMarket Cap
- HealthSector
- -52.94%3M Drawdown
- $1.91BEnterprise Value
- -Dividend Yield
- 10 daysTypical Hold Time
ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.85B, with an enterprise value of $1.91B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.94%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 10 days, indicating typical investor behavior on the platform.
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Most Recent News
OpenAI plans major upgrade to boost ChatGPT amid IPO and competition with Anthropic.
OpenAI is preparing its biggest upgrade yet, transforming ChatGPT into a superapp with multiple tools like coding and AI agents to better compete with Anthropic. This move aims to attract more corporate clients and increase revenue as OpenAI readies ...

Investors may claim losses after ADMA Biologics shares fell 16.6% amid fraud allegations.
Rosen Law Firm is investigating securities claims against ADMA Biologics following allegations that the company misled investors by inflating revenue through channel stuffing. The stock dropped 16.6% on March 24, 2026, after a short seller report by ...

Anthropic co-founder warns AI industry lacks a 'brake pedal' amid rapid growth and IPO plans.
Anthropic, an AI company backed by Amazon and Google, is preparing for a major IPO potentially valuing it near $1 trillion. Co-founder Jack Clark cautions that the AI industry currently has no mechanism to slow development, likening it to having a ga...
